Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 +0.00 (+0.14%)
As of: Sep 30, 2026 · 1:34 PM EDT

Fulcrum Therapeutics, Inc. (FULC) Revenue (2020 - 2024)

Updated

Fulcrum Therapeutics' Revenue was $80 million in FY2024, compared with $2.81 million in FY2023.

Analysis

Fulcrum Therapeutics, Inc. (FULC) Revenue (2020 - 2024) Analysis & Trends

From FY2020 onward, Fulcrum Therapeutics has reported Revenue for 5 years.

  • Revenue shows a four-year compound annual growth rate of 73.5% (FY2020 to FY2024).
  • The FY2024 figure marks the highest annual Revenue in data going back to FY2020.
  • Per Business Quant data, Revenue in earlier years was $2.81 million in FY2023 (-55.8%), $6.34 million in FY2022 (-66.9%), $19.16 million in FY2021 (+117.2%) and $8.82 million in FY2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 80.00 Mn
Dec 31, 2023 871,000.00
Sep 30, 2023 759,000.00
Jun 30, 2023 880,000.00
Mar 31, 2023 295,000.00
Dec 31, 2022 685,000.00
Sep 30, 2022 1.18 Mn
Jun 30, 2022 1.88 Mn
Mar 31, 2022 2.59 Mn
Dec 31, 2021 5.06 Mn
Sep 30, 2021 4.94 Mn
Jun 30, 2021 4.38 Mn
Mar 31, 2021 4.79 Mn
Dec 31, 2020 4.23 Mn
Sep 30, 2020 1.85 Mn
Jun 30, 2020 2.00 Mn
Mar 31, 2020 750,000.00
API Access

Fulcrum Therapeutics, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=FULC&period=max&api_key=YOUR_API_KEY